MapLight Therapeutics, Inc.
MPLT
$30.67
$0.371.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -161.15M | -102.83M | -92.43M | -80.98M | -77.58M |
| Total Depreciation and Amortization | 578.00K | 632.00K | 683.00K | 720.00K | 701.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.27M | 1.04M | 799.00K | 356.00K | 1.13M |
| Change in Net Operating Assets | -12.84M | -11.64M | -9.91M | -4.52M | -3.07M |
| Cash from Operations | -138.14M | -112.80M | -100.86M | -84.42M | -78.82M |
| Capital Expenditure | -473.00K | -203.00K | -546.00K | -768.00K | -770.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -322.73M | -48.06M | 96.51M | -42.52M | -80.02M |
| Cash from Investing | -323.21M | -48.26M | 95.97M | -43.29M | -80.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 276.00M | 134.00K | 37.00K | 295.00K | 294.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 198.87M | 198.87M | 0.00 | 0.00 | 119.96M |
| Repurchase of Preferred Stock | -30.00K | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.02M | -1.14M | -442.00K | -2.24M | -2.19M |
| Cash from Financing | 469.82M | 197.86M | -405.00K | -1.95M | 118.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.48M | 36.80M | -5.30M | -129.66M | -41.54M |